Loading company…
Merganser Biotech develops peptidyl therapeutics for diseases involving iron overload.
Founded in 2011, Merganser Biotech develops peptidyl therapeutics and treatments for diseases involving iron overload.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in